Skip to main content
Duke University Libraries
Search 
  •   DukeSpace
  • Duke Scholarly Works
  • Search
  •   DukeSpace
  • Duke Scholarly Works
  • Search
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-3 of 3

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. 

    Bigner, DD; Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, Sridharan; Herndon, James Emmett II; Marcello, JE; ... (13 authors) (Br J Cancer, 2009-12-15)
    BACKGROUND: We evaluated bevacizumab with metronomic etoposide among recurrent malignant glioma patients in a phase 2, open-label trial. METHODS: A total of 59 patients, including 27 with glioblastoma (GBM) and 32 with grade ...
    Thumbnail

    Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. 

    Abbott, DH; Abernethy, Amy Pickar; Grambow, Steven C; Herndon, James Emmett II; Kolimaga, JT; Marcello, JE; Patwardhan, MB; ... (11 authors) (BMC Cancer, 2008-11-25)
    BACKGROUND: Stage at diagnosis plays a significant role in colorectal cancer (CRC) survival. Understanding which factors contribute to a more advanced stage at diagnosis is vital to improving overall survival. Comorbidity, ...
    Thumbnail

    Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. 

    Dewhirst, Mark Wesley; Herndon, James Emmett II; Rabbani, ZN; Vlahovic, G; Vujaskovic, Z (Br J Cancer, 2006-10-23)
    Elevated intratumoral interstitial fluid pressure (IFP) and tumour hypoxia are independent predictive factors for poor survival and poor treatment response in cancer patients. However, the relationship between IFP and tumour ...
     

     

    Browse

    All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CommunityAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

    My Account

    LoginRegister

    Discover

    Author
    Herndon, James Emmett II (3)
    Marcello, JE (2)Abbott, DH (1)Abernethy, Amy Pickar (1)Bigner, DD (1)Desjardins, A (1)Dewhirst, Mark Wesley (1)Friedman, AH (1)Friedman, HS (1)Grambow, Steven C (1)... View MoreDate Issued2006 (1)2008 (1)2009 (1)TypeJournal article (3)SubjectFemale (3)
    Humans (3)
    Aged (2)Male (2)Middle Aged (2)Vascular Endothelial Growth Factor A (2)Adenocarcinoma (1)Administration, Oral (1)Adult (1)Age Factors (1)... View MoreAffiliation of Duke Author(s)
    Basic Science Departments (3)
    Biostatistics & Bioinformatics (3)
    Clinical Science Departments (3)
    Duke (3)Duke Cancer Institute (3)
    Institutes and Centers (3)
    Medicine (3)Medicine, Medical Oncology (3)School of Medicine (3)Pathology (2)... View More